EICHORPublic-registry site landscape for NCT06294925, “A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis”, a Colitis, Ulcerative study sponsored by Pfizer. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06294925 (registry record) |
| Study title | A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis |
| Official title | Effectiveness of Etrasimod on Disease Activity and Patient-reported Outcomes in Ulcerative Colitis - EFFECT-UC |
| Sponsor | Pfizer |
| Condition(s) | Colitis, Ulcerative |
| Phase | — |
| Listed sites | 38 |
| Site countries | Canada, Germany, United Kingdom |
Patient-friendly overview of this study: eichor.com/study/NCT06294925.
Eichor generates a preliminary site-risk snapshot for NCT06294925 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Colitis, Ulcerative trials
More from Pfizer
← Eichor home · All tracked trials · Colitis, Ulcerative studies · Weekly briefs
